Medicinal Plants as Efficacious Agents for Diabetic Foot Ulcers: A Systematic Review of Clinical Studies.

A diabetic foot ulcer (DFU) is a chronic, nonhealing wound that occurs in approximately 15% to 25% of patients with diabetes, and amputation is necessary in approximately 5% to 24% of these patients. Medicinal plants have demonstrated promising wound healing activities in animal models of DFUs as well as in clinical studies. These plants, which are described as medicinal in different regions of the world, are not considered to be standard medicinal treatments in Western medicine at this time. Some medicinal products, such as bromelain-an herbal protease currently used for enzymatic debridement of wounds-have been obtained from plants, showing the important role of these natural products as sources of wound healing agents. This paper aims to review clinical studies on the effects of medicinal plants in patients with DFUs based on the improvement of local and systemic parameters related to wound healing. Electronic databases including PubMed, Scopus, and Cochrane Library were searched for studies from inception through May 2019 using the keywords "diabetic foot ulcer" and "plant," "phytochemical," "extract," or "herb." Inclusion criteria were controlled or before-after clinical studies with English-language full-text in which topical or systemic herbal preparations for DFUs were evaluated by considering outcomes such as reduction of wound healing time and wound area, markers of inflammation and oxidative stress, and number of cases requiring amputation. Studies on non-herbal materials and human studies other than clinical trials were excluded. Fourteen studies were included in the present review. Herbal medicines were administered as add-on therapy to standard wound care in the form of topical (cream, gel, oil) or systemic (capsule, decoction, injection) preparations. Parameters such as ulcer width and depth, phagocytic function, tumor necrosis factor α level, epithelialization, vascularization, and wound closure were evaluated in clinical trials, several of which were significantly improved in patients compared with their baseline values or control group. Per the studies included in this review, medicinal plants can be recommended as promising adjuvant therapies to conventional wound care to accelerate wound healing in patients with DFUs.

Natural polyphenols for the prevention of irritable bowel syndrome: molecular mechanisms and targets; a comprehensive review.

Irritable bowel syndrome (IBS) is a well diagnosed disease, thoroughly attributed to series of symptoms criteria that embrace a broad range of abdominal complainers. Such criteria help to diagnosis the disease and can guide controlled clinical trials to seek new therapeutic agents. Accordingly, a verity of mechanisms and pathophysiological conditions including inflammation, oxidative stress, lipid peroxidation and different life styles are involved in IBS. Predictably, diverse therapeutic approaches are available and prescribed by clinicians due to major manifestations (i.e., diarrhea-predominance, constipation-predominance, abdominal pain and visceral hypersensitivity), psychological disturbances, and patient preferences between herbal treatments versus pharmacological therapies, dietary or microbiological approaches. Herein, we gathered the latest scientific data between 1973 and 2019 from databases such as PubMed, Google Scholar, Scopus and Cochrane library on relevant studies concerning beneficial effects of herbal treatments for IBS, in particular polyphenols. This is concluded that polyphenols might be applicable for preventing IBS and improving the IBS symptoms, mainly through suppressing the inflammatory signaling pathways, which nowadays are known as novel platform for the IBS management. Graphical abstract.

Leishmanicidal Activity of Withanolides from Aureliana Fasciculata var. Fasciculata.

Leishmaniasis is the generic denomination to the neglected diseases caused by more than 20 species of protozoa belonging to the genus Leishmania. The toxic and parenteral-delivered pentavalent antimonials remain to be the first-line treatment. However, all the current used drugs have restrictions. The species Aureliana fasciculata (Vell.) Sendtner var. fasciculata is a native Brazilian species parsimoniously studied on a chemical point of view. In this study, the antileishmanial activity of A. fasciculata was evaluated. Among the evaluated samples of the leaves, the dichloromethane partition (AFfDi) showed the more pronounced activity, with IC50 1.85 µg/ml against promastigotes of L. amazonensis. From AFfDi, two active withanolides were isolated, the Aurelianolides A and B, with IC50 7.61 µM and 7.94 µM, respectively. The withanolides also proved to be active against the clinically important form, the intracellular amastigote, with IC50 2.25 µM and 6.43 µM for Aurelianolides A and B, respectively. Furthermore, withanolides showed results for in silico parameters of absorption, distribution, metabolism, excretion, and toxicity (ADMET) similar to miltefosine, the reference drug, and were predicted as good oral drugs, with the advantage of not being hepatotoxic. These results suggest that these compounds can be useful as scaffolds for planning drug design.

Separation of Volatile Metabolites from the Leaf-Derived Essential Oil of Piper mollicomum Kunth (Piperaceae) by High-Speed Countercurrent Chromatography.

The technique of high-speed countercurrent chromatography was applied to the isolation of compounds in essential oil derived from the leaves of Piper mollicomum species. Plant leaves (200.0 g) were submitted to hydrodistillation in a modified Clevenger apparatus. The resulting crude leaf essential oil was analyzed by gas chromatography with flame ionization detector (GC-FID) and gas chromatography-mass spectrometry (GC-MS) to determine the profile of the components. The purified fractions were composed of monoterpenes and sesquiterpenes such as camphor (85.0 mg at 98.5% purity), (E)-nerolidol (100.0 mg at 92.8% purity), and camphene (150.0 mg at 82.0% purity). A minor component of the essential oil, bornyl acetate (16.2 mg at 91.2% purity) was also isolated in the one-step separation protocol in 2 h. The countercurrent chromatography technique proved to be a fast and efficient method for the separation of volatile metabolites that conserved the solvent while delivering various fractions of high purity.

Aloysia citrodora Paláu (Lemon verbena): A review of phytochemistry and pharmacology.

ETHNOPHARMACOLOGICAL RELEVANCE: Aloysia citrodora Paláu (Lippia citriodora Kunth), commonly known as "lemon verbena" is a medicinal plant native to South America, North Africa, and South of Europe which is used by native people for several indications such as diarrhea, flatulence, insomnia, and rheumatism. AIM OF THE REVIEW: Despite the wide biological activities of lemon verbena, there is no current review summarizing medicinal properties of the plant; thus, this paper aims to discuss current state of the art regarding the phytochemistry, pharmacology, and therapeutic applications of A. citrodora considering in vitro, in vivo, and clinical studies. MATERIALS AND METHODS: Electronic databases including PubMed, Scifinder, Cochrane library, Scopus, and Science direct were searched with the scientific name of the plant and its synonyms, as well as the common name. All studies on the ethnobotany, phytochemistry, pharmacology, and clinical application of the plant until October 2017 were included in this review. RESULTS: Despite the few number of studies on the ethnopharmacology of the plant, A. citrodora is widely assessed regarding its phytochemistry and biological activities. Neral and geranial are the main ingredients of the essential oil; whereas verbascoside is the most significant component of the extract. Biological activities such as antioxidant, anxiolytic, neuroprotective, anticancer, anesthetic, antimicrobial, and sedative effects are proved in cell cultures, as well as animal studies. CONCLUSIONS: Several pharmacological activities have been reported for A. citrodora; however, the plant is not fully assessed regarding its safety and efficacy in human. Future well-designed human studies are essential to confirm the therapeutic benefits of this plant in clinical settings.

Active metabolites of the genus Piper against Aedes aegypti: natural alternative sources for dengue vector control / Metabolitos activos del género Piper contra Aedes aegypti: fuentes alternativas naturales para el control de vectores de dengue / Metabolitos secundarios do gènero Piper contra Aedes aegypti: fontes naturais alternativas para o controle do vector da dengue

The mosquito, Aedes aegypti, is the principal vector of the viruses responsible for dengue and dengue hemorrhagic fevers. The mosquito is widespread throughout tropical and sub-tropical regions; its prevalence makes dengue one of the most important mosquito-borne viral diseases in the world occurring annually in more than 100 endemic countries. Because blood is essential to their development cycle, the Aedes species maintains a close association with humans and their dwellings. Fittingly, the most widely adopted strategy to decrease the incidence of these diseases is the control of the mosquito larvae population. The emergence of insecticide-resistant mosquitoes has amplified the interest in finding natural products effective against Aedes aegypti adults, as well as larvae. Plant-derived compounds have played an important role in the discovery of new active entities for vector management as they are safer and have lower toxicity to humans in comparison to conventional insecticides. This review assesses a naturally occurring plant matrix and pure compounds of the Piper species, which have been shown to be active against Aedes aegypti.

El mosquito, Aedes aegypti, es el principal vector del dengue y de la fiebre hemorrágica. El mosquito está diseminado en regiones tropicales y subtropicales. La prevalencia del dengue lo hace una de las enfermedades virales, transmitidas por mosquitos, más importantes en el mundo, ocurriendo anualmente en más de 100 países endémicos. Dado que la sangre es esencial para su ciclo de desarrollo, la especie Aedes mantiene una estrecha relación con los seres humanos y sus viviendas. La estrategia más ampliamente adoptada para disminuir la incidencia de estas enfermedades es el control de las larvas de los mosquitos. La aparición de mosquitos resistentes a los insecticidas ha amplificado el interés en la búsqueda de productos naturales, eficaces contra Aedes aegypti adultos y larvas. Los compuestos derivados de plantas han jugado un papel importante en el descubrimiento de nuevas entidades activas para el control del vector; estos son más seguros y menos tóxicos para los seres humanos en comparación con los insecticidas convencionales. Esta reseña evalúa matrices vegetales de origen natural y compuestos puros de especies Pper, que han demostrado ser activos contra Aedes aegypti.

O mosquito Aedes aegypti é o principal vetor dos virus responsáveis pela dengue e pelas febres hemorrágicas de dengue. O mosquito está generalizado em todas as regioes tropicais e sub-tropicais; a sua prevaléncia torna a dengue uma das doencas virais mais importantes transmitidas por mosquitos no mundo que ocorrem anualmente em mais de 100 países endémicos. Como o sangue é essencial para o seu ciclo de desenvolvimiento, a espécie Aedes mantém uma estreita associacáo com os seres humanos e suas habitacoes. Apropriadamente, a estratégia mais adotada para diminuir a incidència dessas doencas é o controle da populacho de larvas de mosquito. O surgimento de mosquitos resistentes aos inseticidas tem ampliado o interesse em encontrar produtos naturais eficazes contra Aedes aegypti adultos, bem como larvas. Compostos derivados de plantas, tém desempenhado um papel importante na descoberta de novas entidades ativas para gestáo de vetores em que sao mais seguros e possuem baixa toxicidade para os seres humanos, em comparacáo com os insecticidas convencionais. Esta avaliacáo avalia a matriz de plantas que ocorrem naturalmente e compostos puros das espécies de Pifter, que tém se mostrado ativa contra Aedes aegypti.

Caracterização de derivado arilbutanoídico em folhas e raízes de Ottonia anisum Sprengel / Characterization of an arylbutanoic derivative from leaves and roots of Ottonia anisum Sprengel

The family Piperaceae encompasses 5 genera, Piper, Peperomia, Pothomorphe, Ottonia and Sarcorhachis, and approximately 2,000 species widely distributed in the tropical and subtropical regions of the world. Most of the Ottonia species are native to Brazil and they are used in folk medicine as diuretic, salivating, and anaesthetic. Chemical studies of non-polar fractions from leaves and roots of Ottonia anisum Sprengel lead to the isolation of an arylbutanoic metabolite, the 1-butyl-3,4-methylenedioxybezene.

A família Piperaceae é formada por 5 gêneros, Piper, Peperomia, Pothomorphe, Ottonia e Sarcorhachis, com cerca de 2000 espécies de ampla distribuição nas regiões tropicais e subtropicais do mundo. Das 23 espécies descritas para o gênero Ottonia, a maioria é nativa do Brasil. Essas plantas são popularmente utilizadas no país como diuréticas, salivantes e anestésicas. O estudo químico dos extratos apolares de folhas e de raízes de Ottonia anisum Sprengel levou aoisolamento de um componente majoritário identifi cado como o derivado arilbutanoídico: 1-butil-3,4-metilenodioxibeneno.